IRCT2014042617443N1已完成未知
Intracameral Bevacizumab and Trabeculectomy Versus Trabeculectomy With Mitomycin C Alone for Open Angle Glaucoma: A clinical trial
Teharn University of Medical Sciences0 个研究点目标入组 51 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 51
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50 years 至 no limit（—）
- 性别
- All
入选标准
- •primary openagle glaucoma candidate for trabeculectomy; pseudoexfoliative glaucoma candidate for trabeculectomy
- •Exclusion criteria: age<50 ; high risk patients for cardiovascular disease
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Bevacizumab Versus Mitomycin C as Trabeculectomy Adjuvant in Uncontrolled GlaucomaGlaucomaNCT02901236Athens Vision Eye Institute40
已完成
4 期
Use of Bevacizumab in Trabeculectomy SurgeryGlaucomaFibrosisOptic NeuropathyNCT01166594Sunnybrook Health Sciences Centre59
已完成
不适用
Intra ocular injection of Bevacizumab and Triamcinolone for diabetic visual loss.CTRI/2014/09/005070ethradhama Superspeciality Eye Hospita15
已完成
2 期
effect of Bevacizumab alone or in combination with 1 mg Triamcinolone for treatment of diabetic retina swellingDiabetic retinopathyDiabetic Macular Edema.IRCT2014080818733N1vice-chancellor for research-Tehran University of Medical Science50
已完成
不适用
Intravitreal bevacizumab treatment for severe retinopathy of prematuritysevere retinopathy of prematurityJPRN-UMIN000018122The Jikei University School of Medicine Department of Ophthalmology6